Antonello Pietrangelo

Dr. Antonello Pietrangelo


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in The Lancet Rheumatology
Verified
Journal Article
Closed access
GGGiovanni Guaraldi
Giovanni Guaraldi
MMMarianna Meschiari
Marianna Meschiari
ACAlessandro Cozzi-Lepri
Alessandro Cozzi-Lepri
JMJovana Milic
Jovana Milic
Roberto TonelliRoberto Tonelli
Roberto Tonelli
CMCristina Mussini
Cristina Mussini

3 June 2004 in New England Journal of Medicine
Verified
Journal Article
Closed access
APAntonello Pietrangelo
Antonello Pietrangelo
For many years, hereditary hemochromatosis was regarded as a clinically and genetically unique entity marked by a classic presentation consisting of diabetes, bronze skin pigmentation, and cirrhosis. In 1996, identification of “the hemochromatosis gene,” HFE, was reported; since then, several other iron-metabolism genes have also been identified. This article reviews the current understanding and management of hereditary iron-overload disorders.

6 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SBSara De Biasi
Sara De Biasi
MMMarianna Meschiari
Marianna Meschiari
LGLara Gibellini
Lara Gibellini
CBCaterina Bellinazzi
Caterina Bellinazzi
RBRebecca Borella
Rebecca Borella
ACAndrea Cossarizza
Andrea Cossarizza
The immune system of patients infected by SARS-CoV-2 is severely impaired. Detailed investigation of T cells and cytokine production in patients affected by COVID-19 pneumonia are urgently required. Here we show that, compared with healthy controls, COVID-19 patients’ T cell compartment displays several alterations involving naïve, central memory, effector memory and terminally differentiated cells, as well as regulatory T cells and PD1+CD57+ exhausted T cells. Significant alterations exist also in several lineage-specifying transcription factors and chemokine receptors. Terminally differentiated T cells from patients proliferate less than those from healthy controls, whereas their mitochondria functionality is similar in CD4+ T cells from both groups. Patients display significant increases of proinflammatory or anti-inflammatory cytokines, including T helper type-1 and type-2 cytokines, chemokines and galectins; their lymphocytes produce more tumor necrosis factor (TNF), interferon-γ, interleukin (IL)-2 and IL-17, with the last observation implying that blocking IL-17 could provide a novel therapeutic strategy for COVID-19.

1 March 2009 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BJBilly Andriopoulos Jr
Billy Andriopoulos Jr
ECElena Corradini
Elena Corradini
YXYin Xia
Yin Xia
SFSarah A Faasse
Sarah A Faasse
SCShanzhuo Chen
Shanzhuo Chen
JBJodie L Babitt
Jodie L Babitt

1 August 2010 in Gastroenterology
Verified
Journal Article
Closed access
APAntonello Pietrangelo
Antonello Pietrangelo

5 April 2018 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
PBPierre Brissot
Pierre Brissot
APAntonello Pietrangelo
Antonello Pietrangelo
PAPaul C. Adams
Paul C. Adams
BGBarbara de Graaff
Barbara de Graaff
CMChristine E. McLaren
Christine E. McLaren
OLOlivier Loréal
Olivier Loréal